BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12900406)

  • 21. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
    Batra J; Robinson J; Soares AS; Fields AP; Radisky DC; Radisky ES
    J Biol Chem; 2012 May; 287(19):15935-46. PubMed ID: 22427646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.
    Bourboulia D; Jensen-Taubman S; Rittler MR; Han HY; Chatterjee T; Wei B; Stetler-Stevenson WG
    Am J Pathol; 2011 Nov; 179(5):2589-600. PubMed ID: 21933655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4.
    Fernández CA; Moses MA
    Biochem Biophys Res Commun; 2006 Jun; 345(1):523-9. PubMed ID: 16682001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
    Sulochana KN; Fan H; Jois S; Subramanian V; Sun F; Kini RM; Ge R
    J Biol Chem; 2005 Jul; 280(30):27935-48. PubMed ID: 15923192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms.
    Akahane T; Akahane M; Shah A; Connor CM; Thorgeirsson UP
    Exp Cell Res; 2004 Dec; 301(2):158-67. PubMed ID: 15530852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK.
    Oh J; Seo DW; Diaz T; Wei B; Ward Y; Ray JM; Morioka Y; Shi S; Kitayama H; Takahashi C; Noda M; Stetler-Stevenson WG
    Cancer Res; 2004 Dec; 64(24):9062-9. PubMed ID: 15604273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase-2 (TIMP-2) in normal and transformed chicken embryo fibroblasts.
    Aimes RT; Li LH; Weaver B; Hawkes S; Hahn-Dantona EA; Quigley JP
    J Cell Physiol; 1998 Mar; 174(3):342-52. PubMed ID: 9462696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A).
    Troeberg L; Tanaka M; Wait R; Shi YE; Brew K; Nagase H
    Biochemistry; 2002 Dec; 41(50):15025-35. PubMed ID: 12475252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2.
    Stetler-Stevenson WG
    Cancer Metastasis Rev; 2008 Mar; 27(1):57-66. PubMed ID: 18058195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
    Ardi VC; Kupriyanova TA; Deryugina EI; Quigley JP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20262-7. PubMed ID: 18077379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27.
    Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A
    Brain Tumor Pathol; 2001; 18(2):89-100. PubMed ID: 11908879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.
    Lee MS; Jung JI; Kwon SH; Lee SM; Morita K; Her S
    PLoS One; 2012; 7(4):e35710. PubMed ID: 22545131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.
    Murphy AN; Unsworth EJ; Stetler-Stevenson WG
    J Cell Physiol; 1993 Nov; 157(2):351-8. PubMed ID: 7693724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum.
    Zhang B; Moses MA; Tsang PC
    Reprod Biol Endocrinol; 2003 Nov; 1():85. PubMed ID: 14613539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
    Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
    Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
    Chuang CH; Liu CH; Lu TJ; Hu ML
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenic activity of trabectedin in myxoid liposarcoma: involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1.
    Dossi R; Frapolli R; Di Giandomenico S; Paracchini L; Bozzi F; Brich S; Castiglioni V; Borsotti P; Belotti D; Uboldi S; Sanfilippo R; Erba E; Giavazzi R; Marchini S; Pilotti S; D'Incalci M; Taraboletti G
    Int J Cancer; 2015 Feb; 136(3):721-9. PubMed ID: 24917554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.